Exelixis, Inc. ( EXEL) - Key Metrics
EXEL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.20 | $0.90 | $1.23 | $1.22 |
| 2025Q3 | $2.23 | $0.72 | $1.08 | $1.08 |
| 2025Q2 | $2.08 | $0.68 | $0.18 | $0.18 |
| 2025Q1 | $1.99 | $0.57 | $0.76 | $0.68 |
EXEL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 12.10 |
| 2025Q3 | ? | 13.90 |
| 2025Q2 | ? | 17.01 |
| 2025Q1 | ? | 15.10 |
EXEL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 2.20% | ? |
| 2025Q4 | 2.81% | ? |
| 2025Q3 | 2.68% | ? |
| 2025Q2 | 0.36% | ? |
| 2025Q1 | 1.96% | ? |
EXEL
Price: $55.37
52 week price:
Earnings Per Share: 3.02 USD
P/E Ratio: 16.46
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 986798
Ebitda: 84.9 millionMarket Capitalization: 14.0 billion